BTAI icon

BioXcel Therapeutics

116 hedge funds and large institutions have $475M invested in BioXcel Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
-1
Holders Change %
-0.85%
% of All Funds
2.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
51
Reduced
32
Closed
19
Calls
$11.3M
Puts
$10.5M
Net Calls
+$828K
Net Calls Change
-$16.2M
Name Holding Trade Value Shares
Change
Shares
Change %
OCM
126
Ovata Capital Management
Hong Kong
-$231K -313 Closed
TC
127
TwinBeech Capital
New York
-$208K -282 Closed
SO
128
STRS Ohio
Ohio
-$184K -250 Closed
OSAM
129
O'Shaughnessy Asset Management
Connecticut
-$40K -54 Closed
Barclays
130
Barclays
United Kingdom
-$22K -30 Closed
ASN
131
Advisory Services Network
Georgia
-$15K -20 Closed
QT
132
Quantbot Technologies
New York
-$13K -19 Closed
AF
133
Allworth Financial
California
-$10K -13 Closed
RPWA
134
Regent Peak Wealth Advisors
Georgia
-$5K -6 Closed